insights_auto
Why is ARX down २.९७%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$ ०.४९
arrow_downward
-२.९७%(-०.०१५) 1D
नोभेम्बर १९, १६:१०:०३ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$ ०.४९
High
A$ ०.५१
Low
A$ ०.४९
Mkt. cap
१६.३७ करोड
Avg. vol.
२.५९ लाख
Volume
२.४६ लाख
P/E ratio
४६.६७
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
Open
A$ ०.४९
High
A$ ०.५१
Low
A$ ०.४९
Mkt. cap
१६.३७ करोड
Avg. vol.
२.५९ लाख
Volume
२.४६ लाख
P/E ratio
४६.६७
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
News stories
From web sources and news partners
BigGo Finance
·
४३ मिनेट पहिले
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
Stocktwits
·
१ घण्टा पहिले
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
BeInCrypto
·
२ घण्टा पहिले
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
Traders Union
·
३ घण्टा पहिले
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd